Pharmaceutical Secondary Packaging Market Outlook from 2025 to 2035

The size of the pharmaceutical secondary packing industry was approximately USD 45.2 billion in 2025 and may grow up to a value of USD 72.8 billion by the year 2035. It may expand its roots through sales in terms of increasing 4.9% on CAGR a period considered is 2025 to 2035.

Pharmaceutical secondary packaging plays an important role in maintaining product integrity, compliance, and branding. The industry shall account for more than 60.3% of the industry share of the pharmaceutical packaging business by 2035. Driven by an increasing demand for serialization, track-and-trace systems, and tamper-evident packs, secondary packaging solutions are progressing to address regulations and industry specifications.

Pharmaceutical Secondary Packaging Market

Among packaging forms, folding cartons are likely to lead with over 55% industry share. Folding cartons are highly favored because they are cost-effective, printable for branding, and feature-compliant. Rigid boxes and corrugated cases, on the other hand, are increasingly popular for high-value pharmaceutical products that need additional protection.

The industry for pharmaceutical secondary packaging is set to provide an incremental opportunity of USD 27.6 billion, 1.6 times its current value by 2035.

Explore FMI!

Book a free demo

Semi-Annual Market Update

The following table provides the anticipated CAGR for the secondary packaging industry of pharmaceuticals over a number of half-decade periods from 2025 to 2035.

Particular Value CAGR
H1 5.1% (2024 to 2034)
H2 4.7% (2024 to 2034)
H1 4.5% (2025 to 2035)
H2 5.3% (2025 to 2035)

During the first half (H1) of the decade between 2024 and 2034, the industry is anticipated to develop at a CAGR of 5.1%, and in the second half (H2) of the same decade, the growth is expected to be slightly less at 4.7%. Progressing to the next time frame, H1 2025 to H2 2035, the CAGR is anticipated to go down slightly to 4.5% for the first half and go up to 5.3% for the second half. The initial half (H1) experienced a drop of 60 BPS, whereas for the second half (H2), the industry experienced an increase of 80 BPS.f.

Key Industry Highlights

Stringent Regulations and Serialization Fuel Market Growth

Regulatory trends, including serialization requirements from regulators such as the FDA and EMA, are driving pharma manufacturers to invest in advanced secondary packaging technologies that enable increased traceability and compliance.

Rising demand for sustainable packaging solution

Growing pressure related to sustainability is pushing pharmaceutical companies towards the integration of environment friendly secondary packaging materials such as recyclable folding cartons and biodegradable packaging materials. This evolution is driven by consumer choice and corporate sustainability goals.

Challenges in Cost and Supply Chain Management

The demand for secondary packaging in pharmaceuticals is threatened by price volatility in raw materials and supply chain issues. In addition, serialization and track-and-trace technology adoption improves packaging spending. However, the technological transition toward digital printing and automation is expected to deliver cost efficiencies in the long term.

Manufacturer Adaptation: Key Areas of Investment 2025 to 2035

Key Investment Area Why It’s Critical for Future Growth
Smart & Connected Packaging Decrease patient noncompliance, trace the authenticity of products, and increase the transparency of the supply chain.
Automation & AI in Packaging Lines To be accurate, make fewer mistakes, and act according to strict guidelines.
Sustainable & Recyclable Materials To fit well in including into the global re of sustainability goals and reduce the environment degradation.
Tamper-Evident & Anti-Counterfeit Features To ensure product safety and face the growing incidence of counterfeit medications.
Government Collaboration & Compliance To comply with changing global pharmaceutical packaging regulations and achieve faster industry approvals.

2020 to 2024 Global Pharmaceutical Secondary Packaging Market Sales Outlook Compared to Demand Forecast from 2025 to 2035

In the preceding years, the global pharmaceutical secondary packaging industry observed a significant transition of adapting recyclable and biodegradable packaging, with raw materials mainly made out of paperboard, plastics, and aluminum-based material. Automation was rapidly integrated with packaging lines, as well as serialization to ensure tracking.

Regulatory impact was strong, with serialization mandates and anti-counterfeiting technologies, and the boom in e-commerce created greater demand for durable secondary packaging.

By 2025 to 2035, there should be a whole-hearted commitment to zero-waste pharmaceutical packaging, with much greater levels of plant based bioplastics, recycled content and compostable pharmaceutical packaging options. AI-smart packaging will be a key enabler of supply chain optimization thanks to features such as smart labels, NFC tags, and temperature-sensitive warnings.

Some will be the cost sting of compliance, but cost savings just got better through AI, automation, and material science. The industry will broaden to include more than just pharmaceuticals, expanding into biotech, nutraceuticals and more personalized medicine. The impact of e-commerce will only grow, resulting in the widespread adoption of tamper-proof, e-commerce-friendly packaging.

Market Concentration

The tier 1 players dominate the global secondary packaging industry for pharmaceuticals with a significant industry share. They feature high production capacities and a diverse product portfolio. At a basic level, they invest in advanced technology, green solutions, and regulatory compliance in order to enable high-quality products.

Tier 2 companies are middle-sized companies with strong regional presence and high value in the domestic sectors. They have good regulation and technology awareness but lack of advanced technology and world-wide coverage of tier 1 players. Tier 2 players target niche applications and customized pharmaceutical secondary pack solutions. Major companies in tier 2 are Constantia Flexibles, Winpak Ltd., CCL Industries, Sonoco Products Company, and UFlex Limited.

Tier 3 businesses of small companies operating at a local level, serving region-specific demands. Operators are largely busy fulfilling the needs of the local industry and the operators are considered an unorganized sector as compared to organized sector of tier 1 and tier 2 operators.

Region-Wise Trends: Past Analysis 2020 to 2024 and Future Projections 2025 to 2035

Asia-Pacific (APAC)

The large growth in 2020 and 2024 was driven by increased pharmaceutical production in India and China where more concentration on global regulatory compliance has emphasized. However, in the coming time period of 2025 to 2035 the growth will be driven by increasing demand for blister packs, cartons and flexible packaging types along with investment in sustainable and child-resistant packaging.

Europe

Strong uptake of serialization and tamper-evident packaging use in 2020 and also 2024 were also due to tight EU regulations in pharma packaging safety and sustainability. But, during 2025 to 2035 the industry of pharma packaging will marked by stringent waste minimization policies by EU and growing adoption of digital & intelligent packaging technologies.

Latin America

Moderate growth was witnessed in 2020 and 2024 underpinned by growing pharmaceutical exports from Brazil and Mexico, although cost limitation slowed the universal uptake of sophisticated packaging.

Growth will speed up by 2035 as regulatory systems improve and local capacity for manufacturing builds, helping to curtail import reliance.

Middle East & Africa (MEA)

Adoption was slow in 2020 to 2024 as a result of less stringent legislation and reduced local pharmaceutical production. Governments are currently imposing stricter pharmaceutical safety and packaging requirements, however, with greater investment in local pharmaceutical production likely to stimulate demand by 2035.

North America

The USA and Canada spearheaded industry growth through sophisticated packaging solutions and stringent regulatory compliance, with serialization becoming compulsory for packaging of drugs in past decades.

However during 2025 and 2035, more stringent FDA and Health Canada regulations will spur innovations in secondary packaging, with a heightened demand for environmentally friendly and intelligent packaging solutions.

South Asia

Limited uptake occurred from 2020 to 2024 as a result of cost-conscious sectors and the absence of sophisticated packaging infrastructure, although a few companies tested biodegradable ones. In 2025 to 2035 Indian and Bangladeshi governments are implementing more stringent pharma packaging regulations, which will fuel growth in local drug production and contract packaging.

Country-wise Insights

Countries Value CAGR (2025 to 2035)
United States 6.2%
India 8.0%
Germany 4.8%
China 6.5%
Brazil 3.9%
United Kingdom 5.1%
Canada 4.3%

Increasing Demand for Smart Packaging in the USA

Aspects that boost demand for pharmaceutical secondary packaging in the United States are the adoption of smart packaging solutions. Use of QR codes, RFID tracking, and tamper-evident seals enables secure drug safety, compliance and traceability. The increasing focus on patient safety and compliance with regulations is enhancing sector growth.

Sustainability and Compliance Fuel Market Growth in Germany

Due to stringent EU legislation on waste and recycling, Germany is leading the charge in sustainable secondary pharma packaging. There is still a call by customers for biodaygadeable, recyclable, and sustainable pharma packaging especially in the prescription drug and over-the-counter (OTC) medicine segments. To reduce environmental impact while maintaining product quality, German converters are increasingly investing in light-weight, high-barrier papaer-based materials.

Category-wise Insights

Cartons & Boxes Dominate Due to Wide-Scale Use in Pharmaceutical Packaging

Packaging Type Market Share (2025)
Cartons & Boxes 54.2%

As per the recent trend, cartons & boxes continue to account for the most common type of secondary pharmaceutical packaging owing to their versatility, lightweight and ability to offer space for branding. They are used extensively for blister packs, bottles, vials, and ampoules in order to protect them against external contamination, light and mechanical shock.

Folding Cartons & Rigid Boxes Market: Key Drivers and Challenges Different types of drugs have different tamper-evident packaging legislation requirements, and the demand for child-resistant packaging systems is increasing.

Paperboard Leads Due to Sustainability and Recyclability

Material Type Market Share (2025)
Paperboard 63.8%

The pharma industry is moving towards environmentally friendly packaging, and paperboard is the most preferred material for secondary packaging. Due to its high recyclability, cost benefits, and lightweight, it can be used in cartons, labels, and inserts.

While the government further enforces control of plastic usage, pharmaceutical corporations now increasingly use biodegradable and FSC-approved paperboard packaging to aid sustainability without compromising packaging integrity and compliance.

Competitive Landscape

By 2025 and beyond, key players in the pharmaceutical secondary packaging sector are prioritizing sustainability, digitalization, and compliance-driven innovations. WestRock Company is increasing FSC-certified & child-resistant cartons, and Amcor Plc is putting resources into smart packaging with track-and-trace systems.

Mondi Group is focused on sustainable development of 100% recyclable and compostable packaging, and Sonoco Products Company is developing temperature-resistant and protective pharmaceutical packaging.

Gerresheimer AG is adding RFID and NFC smart labels, and Huhtamaki is creating biodegradable paper-based blister packs. Constantia Flexibles is improving cold-chain secondary packaging for biologics Custom-molded fiber trays for sterile medical devices is one area receiving attention at UFP Technologies, while Clondalkin Group is adding to tamper-evident and anti-counterfeiting attributes. Rondo-Pak is innovating and nurturing sustainable and intelligent packaging solutions.

By 2035, the industry is expected to be fully aligned with circular economy principles, leveraging AI-driven packaging solutions, automation, and stricter regulatory frameworks to enhance drug safety, reduce environmental impact, and improve supply chain efficiency.

Key Developments in the Pharmaceutical Secondary Packaging Market

Company Strategy Development
Product Launch WestRock introduced a new line of child-resistant, recyclable paperboard packaging for pharmaceuticals, enhancing safety and sustainability.
Partnership Amcor partnered with Novo Nordisk to develop high-barrier, recyclable secondary packaging for temperature-sensitive medications.
Acquisition Metsä Board completed the acquisition of A&R Carton to expand its sustainable pharmaceutical packaging capabilities across Europe.
Certification Huhtamaki achieved ISO 15378 certification for its pharmaceutical secondary packaging, ensuring compliance with global quality standards.
Acquisition Sonoco acquired ThermoSafe, strengthening its position in temperature-controlled pharmaceutical packaging.
Product Innovation Gerresheimer launched tamper-evident secondary packaging for injectable drugs, improving patient safety and regulatory compliance.

Vendor Insights in the Pharmaceutical Secondary Packaging Industry

Manufacturer Vendor Insights
WestRock Innovations in sustainable and child-resistant pharmaceutical packaging.
Amcor Developed sustainable forms of secondary packaging that have high barriers and helps to grow their market share
Metsä Board Instituted acquisitions and sustainable paperboard packaging solutions to make its presence stronger in Europe.
Huhtamaki Specialized in regulatory strictures and high quality pharmaceutical packaging solutions.
Sonoco Built its capacity in temperature-controlled pharmaceutical packaging via acquisitions.
Gerresheimer Retained its industrial position with the introduction of tamper-evident and high barrier packaging innovations
Berry Global Diversified and expanded its pharmaceutical packaging business with an emphasis on sustainability and material efficiency
Schreiner MediPharm Managed its industrial share with smart labels and interactive secondary packaging solutions
CCL Industries Growing focus of pharmaceutical manufacturers to invest in security features for their cartons and labels.
Körber Pharma Packaging Consolidating its position with automation solutions in pharmaceutical secondary packaging
Graphic Packaging International Delivered against industry growth through lightweight, recyclable secondary packaging innovations.
Constantia Flexibles Strengthened pharmaceutical domain with advanced high-barrier film based secondary packaging.

Key Players in the Pharmaceutical Secondary Packaging Market

  • WestRock
  • Amcor
  • Metsä Board
  • Huhtamaki
  • Sonoco
  • Gerresheimer
  • Berry Global
  • Schreiner MediPharm
  • CCL Industries
  • Körber Pharma Packaging
  • Graphic Packaging International
  • Constantia Flexibles

Road Ahead: Future Considerations for Stakeholders

The pharmaceutical secondary packaging industry is anticipated to grow steadily, spurred by growing regulatory demands and sustainability efforts.

To maintain tracing and authenticity smart packaging options such as RFID, QR code, and NFC should also be adopted. Investment in automation and the digitization of processes will contribute to greater efficiency in manufacturing and more temperature-controlled packaging options in the case of biologics and temperature-sensitives drugs are needed.

By following these tactics, businesses are able to propel innovation and enforce compliance in the emerging pharmaceutical secondary packaging industry.

Frequently Asked Questions

What is the future of the pharmaceutical secondary packaging industry?

The industry is predictive to observe a CAGR of 4.9% between 2025 and 2035.

What was the worth of the pharmaceutical secondary packaging industry in 2024?

The global industry stood at USD 43.5 billion in 2024.

What will be the worth of the global pharmaceutical secondary packaging industry by 2035?

The industry is anticipated to reach USD 72.8 billion by 2035.

Which region will showcase the highest CAGR during the forecast period?

Asia-Pacific is expected to record the highest CAGR, driven by pharmaceutical market expansion and regulatory reforms.

Who are the key players in the global pharmaceutical secondary packaging industry?

Some of the key players include WestRock, Amcor, Metsä Board, and Huhtamaki.

Table of Content
  1. Executive Summary
  2. Industry Introduction, including Taxonomy and Market Definition
  3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
  4. Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
  5. Pricing Analysis
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
    • Packaging
    • Application
    • End User
    • Material
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Packaging
    • Folding Cartons
      • Paperboard Boxes
      • Pouches & Sachets
      • Labels & Leaflets
      • Blister Cards
      • Clamshells and Wrap-Around Packaging
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Application
    • Ophthalmic
    • Injectable
    • Biologics
    • Wound Care
    • Respiratory
    • Therapy
    • Oral
  9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End User
    • Pharmaceutical Companies
    • Contract Packaging Organizations (CPOs)
    • Retail Pharmacies
    • Hospitals & Clinics
  10. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Material
    • Paperboard
    • Corrugated Board
    • Plastics
    • Aluminium Foil
    • Glass
  11. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • North America
    • Latin America
    • Western Europe
    • South Asia
    • East Asia
    • Eastern Europe
    • Middle East & Africa
  12. North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  13. Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  14. Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  15. South Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  16. East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  17. Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  18. Middle East & Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
  19. Sales Forecast 2025 to 2035 by Packaging, Application, End User, and Material for 30 Countries
  20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
  21. Company Profile
    • WestRock
    • Amcor
    • Metsä Board
    • Huhtamaki
    • Sonoco
    • Gerresheimer
    • Berry Global
    • Schreiner MediPharm
    • CCL Industries
    • Körber Pharma Packaging
    • Graphic Packaging International
    • Constantia Flexibles

Pharmaceutical Secondary Packaging Market Segmentation

By Packaging Type:

Folding Cartons, Paperboard Boxes, Pouches & Sachets, Labels & Leaflets, Blister Cards, Clamshells and Wrap-Around Packaging

By Material Type:

Paperboard, Corrugated Board, Plastics, Aluminium Foil, Glass

By Application:

Ophthalmic, Injectable, Biologics, Wound Care, Respiratory, Therapy, Oral

By End Use:

Pharmaceutical Companies, Contract Packaging Organizations (CPOs), Retail Pharmacies, Hospitals & Clinics

By Region:

North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa

Explore Packaging Insights

Intelligent Packaging Market

Intelligent Packaging Market Growth & Industry Forecast 2025 to 2035

Labeling Equipment Market

Labeling Equipment Market by Product Type, Technology, Labeling Type, End Use Industry & Region - Forecast 2025 to 2035

Kraft Packaging Market

Kraft Packaging Market Trends - Growth & Forecast 2025 to 2035

Flexible Frozen Food Packaging Market

Flexible Frozen Food Packaging Market Growth - Forecast 2025 to 2035

Flexible Thin Film Market

Flexible Thin Film Market Trends - Growth & Forecast 2025 to 2035

Hydrogel Market

Hydrogel Market Demand & Technological Advances 2025-2035

Future Market Insights

Pharmaceutical Secondary Packaging Market